日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.

转移性结直肠癌患者节拍式伊立替康的药代动力学和药效学研究

Allegrini G, Falcone A, Fioravanti A, Barletta M T, Orlandi P, Loupakis F, Cerri E, Masi G, Di Paolo A, Kerbel R S, Danesi R, Del Tacca M, Bocci G

Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan

对一种解释抗癌药物伊立替康产生不良胆碱能作用的新机制进行表征

Blandizzi, C; De Paolis, B; Colucci, R; Lazzeri, G; Baschiera, F; Del Tacca, M

Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas

非霍奇金淋巴瘤抗癌药物的药物遗传学

Loni, L; Del Tacca, M; Danesi, R

Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane

苏拉明抑制鸡胚绒毛尿囊膜中bFGF诱导的内皮细胞增殖和血管生成

Danesi, R; Del Bianchi, S; Soldani, P; Campagni, A; La Rocca, R V; Myers, C E; Paparelli, A; Del Tacca, M